Ellsworth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Ellsworth Advisors's AMGN Position: Q2 2026 in Review
Ellsworth Advisors reduced its Amgen (AMGN) stake by 23% in Q2 2026, selling an estimated $2.31M and leaving 22,329 shares worth $8M. The position accounts for 1.31% of the portfolio, ranked #26.
Ellsworth Advisors first reported a position in AMGN in Q4 2020 and has held it in 10 quarters since. The position peaked at $10.2M in Q1 2026. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ellsworth Advisors held 22,329 shares of Amgen worth $8M as of Q2 2026.
- Ellsworth Advisors sold 6,760 Amgen shares in Q2 2026, an estimated $2.31M.
- Amgen made up 1.31% of Ellsworth Advisors's portfolio in Q2 2026, its #26 holding.
- Ellsworth Advisors first reported a position in Amgen in Q4 2020 and has held it in 10 quarters since.
- Ellsworth Advisors's Amgen position peaked at $10.2M in Q1 2026.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.